nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—lung cancer	0.588	0.875	CbGaD
Ethacrynic acid—ALB—lung cancer	0.084	0.125	CbGaD
Ethacrynic acid—ALB—Gefitinib—lung cancer	0.0501	0.365	CbGbCtD
Ethacrynic acid—ALB—Erlotinib—lung cancer	0.0296	0.216	CbGbCtD
Ethacrynic acid—ALB—Irinotecan—lung cancer	0.0268	0.195	CbGbCtD
Ethacrynic acid—SLC22A6—Methotrexate—lung cancer	0.0166	0.121	CbGbCtD
Ethacrynic acid—ALB—Methotrexate—lung cancer	0.0142	0.103	CbGbCtD
Ethacrynic acid—GSTA2—respiratory system—lung cancer	0.00148	0.115	CbGeAlD
Ethacrynic acid—GSTA2—epithelium—lung cancer	0.00124	0.0959	CbGeAlD
Ethacrynic acid—ALB—mammary gland—lung cancer	0.00122	0.0946	CbGeAlD
Ethacrynic acid—GSTA2—bronchus—lung cancer	0.00122	0.0944	CbGeAlD
Ethacrynic acid—ATP1A1—mammary gland—lung cancer	0.00118	0.0911	CbGeAlD
Ethacrynic acid—SLC12A1—epithelium—lung cancer	0.00113	0.0872	CbGeAlD
Ethacrynic acid—GSTA2—lung—lung cancer	0.000787	0.0609	CbGeAlD
Ethacrynic acid—ATP1A1—respiratory system—lung cancer	0.000785	0.0607	CbGeAlD
Ethacrynic acid—ATP1A1—epithelium—lung cancer	0.000656	0.0507	CbGeAlD
Ethacrynic acid—ATP1A1—bronchus—lung cancer	0.000646	0.05	CbGeAlD
Ethacrynic acid—ATP1A1—trachea—lung cancer	0.00058	0.0449	CbGeAlD
Ethacrynic acid—ATP1A1—cardiac atrium—lung cancer	0.000545	0.0422	CbGeAlD
Ethacrynic acid—ATP1A1—bone marrow—lung cancer	0.00046	0.0356	CbGeAlD
Ethacrynic acid—ATP1A1—lung—lung cancer	0.000417	0.0322	CbGeAlD
Ethacrynic acid—Asthenia—Teniposide—lung cancer	0.000315	0.00332	CcSEcCtD
Ethacrynic acid—Neutropenia—Etoposide—lung cancer	0.000314	0.00331	CcSEcCtD
Ethacrynic acid—Anorexia—Topotecan—lung cancer	0.00031	0.00327	CcSEcCtD
Ethacrynic acid—Neutropenia—Paclitaxel—lung cancer	0.000308	0.00325	CcSEcCtD
Ethacrynic acid—Malaise—Vinorelbine—lung cancer	0.000307	0.00325	CcSEcCtD
Ethacrynic acid—Anorexia—Erlotinib—lung cancer	0.000307	0.00324	CcSEcCtD
Ethacrynic acid—Vertigo—Vinorelbine—lung cancer	0.000306	0.00323	CcSEcCtD
Ethacrynic acid—Diarrhoea—Teniposide—lung cancer	0.0003	0.00317	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Doxorubicin—lung cancer	0.000299	0.00316	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Docetaxel—lung cancer	0.000298	0.00315	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Paclitaxel—lung cancer	0.000297	0.00313	CcSEcCtD
Ethacrynic acid—ALB—lymph node—lung cancer	0.000296	0.0229	CbGeAlD
Ethacrynic acid—Jaundice—Etoposide—lung cancer	0.000292	0.00308	CcSEcCtD
Ethacrynic acid—Decreased appetite—Vinblastine—lung cancer	0.000291	0.00307	CcSEcCtD
Ethacrynic acid—Chills—Irinotecan—lung cancer	0.00029	0.00306	CcSEcCtD
Ethacrynic acid—Discomfort—Vinorelbine—lung cancer	0.000287	0.00303	CcSEcCtD
Ethacrynic acid—Pain—Vinblastine—lung cancer	0.000286	0.00302	CcSEcCtD
Ethacrynic acid—ATP1A1—lymph node—lung cancer	0.000285	0.0221	CbGeAlD
Ethacrynic acid—Decreased appetite—Topotecan—lung cancer	0.000283	0.00299	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Doxorubicin—lung cancer	0.000283	0.00298	CcSEcCtD
Ethacrynic acid—Chills—Gemcitabine—lung cancer	0.000282	0.00298	CcSEcCtD
Ethacrynic acid—Fatigue—Topotecan—lung cancer	0.00028	0.00296	CcSEcCtD
Ethacrynic acid—Haematuria—Paclitaxel—lung cancer	0.00028	0.00295	CcSEcCtD
Ethacrynic acid—Decreased appetite—Erlotinib—lung cancer	0.00028	0.00295	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Etoposide—lung cancer	0.000279	0.00295	CcSEcCtD
Ethacrynic acid—Vomiting—Teniposide—lung cancer	0.000279	0.00295	CcSEcCtD
Ethacrynic acid—Dysphagia—Docetaxel—lung cancer	0.000279	0.00295	CcSEcCtD
Ethacrynic acid—Pain—Topotecan—lung cancer	0.000278	0.00294	CcSEcCtD
Ethacrynic acid—Fatigue—Erlotinib—lung cancer	0.000277	0.00293	CcSEcCtD
Ethacrynic acid—Rash—Teniposide—lung cancer	0.000277	0.00292	CcSEcCtD
Ethacrynic acid—Dermatitis—Teniposide—lung cancer	0.000276	0.00292	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Vinblastine—lung cancer	0.000276	0.00291	CcSEcCtD
Ethacrynic acid—Pain—Erlotinib—lung cancer	0.000275	0.00291	CcSEcCtD
Ethacrynic acid—Headache—Teniposide—lung cancer	0.000275	0.0029	CcSEcCtD
Ethacrynic acid—Tinnitus—Cisplatin—lung cancer	0.000273	0.00289	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Vinorelbine—lung cancer	0.000272	0.00288	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Topotecan—lung cancer	0.000268	0.00283	CcSEcCtD
Ethacrynic acid—Anorexia—Vinorelbine—lung cancer	0.000265	0.0028	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Irinotecan—lung cancer	0.000261	0.00275	CcSEcCtD
Ethacrynic acid—Neutropenia—Docetaxel—lung cancer	0.000261	0.00275	CcSEcCtD
Ethacrynic acid—Nausea—Teniposide—lung cancer	0.000261	0.00275	CcSEcCtD
Ethacrynic acid—Body temperature increased—Topotecan—lung cancer	0.000257	0.00271	CcSEcCtD
Ethacrynic acid—Body temperature increased—Erlotinib—lung cancer	0.000254	0.00269	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Gemcitabine—lung cancer	0.000254	0.00268	CcSEcCtD
Ethacrynic acid—Malaise—Irinotecan—lung cancer	0.000254	0.00268	CcSEcCtD
Ethacrynic acid—Vertigo—Irinotecan—lung cancer	0.000253	0.00267	CcSEcCtD
Ethacrynic acid—Malaise—Gemcitabine—lung cancer	0.000247	0.00261	CcSEcCtD
Ethacrynic acid—Tinnitus—Paclitaxel—lung cancer	0.000246	0.00259	CcSEcCtD
Ethacrynic acid—Jaundice—Docetaxel—lung cancer	0.000242	0.00256	CcSEcCtD
Ethacrynic acid—Decreased appetite—Vinorelbine—lung cancer	0.000242	0.00255	CcSEcCtD
Ethacrynic acid—Chills—Etoposide—lung cancer	0.000241	0.00255	CcSEcCtD
Ethacrynic acid—Vision blurred—Cisplatin—lung cancer	0.000241	0.00254	CcSEcCtD
Ethacrynic acid—Asthenia—Vinblastine—lung cancer	0.00024	0.00254	CcSEcCtD
Ethacrynic acid—Fatigue—Vinorelbine—lung cancer	0.00024	0.00253	CcSEcCtD
Ethacrynic acid—Pain—Vinorelbine—lung cancer	0.000238	0.00251	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Cisplatin—lung cancer	0.000237	0.0025	CcSEcCtD
Ethacrynic acid—Discomfort—Irinotecan—lung cancer	0.000236	0.0025	CcSEcCtD
Ethacrynic acid—Chills—Paclitaxel—lung cancer	0.000236	0.0025	CcSEcCtD
Ethacrynic acid—Asthenia—Topotecan—lung cancer	0.000233	0.00246	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Docetaxel—lung cancer	0.000232	0.00245	CcSEcCtD
Ethacrynic acid—Confusional state—Irinotecan—lung cancer	0.000231	0.00244	CcSEcCtD
Ethacrynic acid—Asthenia—Erlotinib—lung cancer	0.000231	0.00244	CcSEcCtD
Ethacrynic acid—Discomfort—Gemcitabine—lung cancer	0.00023	0.00243	CcSEcCtD
Ethacrynic acid—Malaise—Cisplatin—lung cancer	0.00023	0.00243	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Vinorelbine—lung cancer	0.000229	0.00242	CcSEcCtD
Ethacrynic acid—Diarrhoea—Vinblastine—lung cancer	0.000229	0.00242	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Irinotecan—lung cancer	0.000225	0.00237	CcSEcCtD
Ethacrynic acid—Diarrhoea—Topotecan—lung cancer	0.000223	0.00235	CcSEcCtD
Ethacrynic acid—Convulsion—Cisplatin—lung cancer	0.000221	0.00234	CcSEcCtD
Ethacrynic acid—Diarrhoea—Erlotinib—lung cancer	0.00022	0.00232	CcSEcCtD
Ethacrynic acid—Body temperature increased—Vinorelbine—lung cancer	0.00022	0.00232	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Gemcitabine—lung cancer	0.000219	0.00231	CcSEcCtD
Ethacrynic acid—Anorexia—Irinotecan—lung cancer	0.000219	0.00231	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Etoposide—lung cancer	0.000217	0.00229	CcSEcCtD
Ethacrynic acid—Anxiety—Cisplatin—lung cancer	0.000217	0.00229	CcSEcCtD
Ethacrynic acid—Vision blurred—Paclitaxel—lung cancer	0.000216	0.00228	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Methotrexate—lung cancer	0.000215	0.00227	CcSEcCtD
Ethacrynic acid—Discomfort—Cisplatin—lung cancer	0.000215	0.00227	CcSEcCtD
Ethacrynic acid—Anorexia—Gemcitabine—lung cancer	0.000213	0.00225	CcSEcCtD
Ethacrynic acid—Vomiting—Vinblastine—lung cancer	0.000213	0.00225	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Paclitaxel—lung cancer	0.000213	0.00225	CcSEcCtD
Ethacrynic acid—Malaise—Etoposide—lung cancer	0.000211	0.00223	CcSEcCtD
Ethacrynic acid—Vertigo—Etoposide—lung cancer	0.00021	0.00222	CcSEcCtD
Ethacrynic acid—Headache—Vinblastine—lung cancer	0.00021	0.00221	CcSEcCtD
Ethacrynic acid—Vomiting—Topotecan—lung cancer	0.000207	0.00218	CcSEcCtD
Ethacrynic acid—Malaise—Paclitaxel—lung cancer	0.000207	0.00218	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Doxorubicin—lung cancer	0.000206	0.00218	CcSEcCtD
Ethacrynic acid—Vertigo—Paclitaxel—lung cancer	0.000206	0.00218	CcSEcCtD
Ethacrynic acid—Rash—Topotecan—lung cancer	0.000205	0.00217	CcSEcCtD
Ethacrynic acid—Dermatitis—Topotecan—lung cancer	0.000205	0.00216	CcSEcCtD
Ethacrynic acid—Vomiting—Erlotinib—lung cancer	0.000205	0.00216	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Cisplatin—lung cancer	0.000204	0.00215	CcSEcCtD
Ethacrynic acid—Headache—Topotecan—lung cancer	0.000204	0.00215	CcSEcCtD
Ethacrynic acid—Rash—Erlotinib—lung cancer	0.000203	0.00214	CcSEcCtD
Ethacrynic acid—Dermatitis—Erlotinib—lung cancer	0.000203	0.00214	CcSEcCtD
Ethacrynic acid—Convulsion—Etoposide—lung cancer	0.000203	0.00214	CcSEcCtD
Ethacrynic acid—Headache—Erlotinib—lung cancer	0.000202	0.00213	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000201	0.00213	CcSEcCtD
Ethacrynic acid—Chills—Docetaxel—lung cancer	0.0002	0.00212	CcSEcCtD
Ethacrynic acid—Asthenia—Vinorelbine—lung cancer	0.0002	0.00211	CcSEcCtD
Ethacrynic acid—Decreased appetite—Irinotecan—lung cancer	0.000199	0.00211	CcSEcCtD
Ethacrynic acid—Nausea—Vinblastine—lung cancer	0.000199	0.0021	CcSEcCtD
Ethacrynic acid—Convulsion—Paclitaxel—lung cancer	0.000199	0.0021	CcSEcCtD
Ethacrynic acid—Anorexia—Cisplatin—lung cancer	0.000199	0.0021	CcSEcCtD
Ethacrynic acid—Fatigue—Irinotecan—lung cancer	0.000198	0.00209	CcSEcCtD
Ethacrynic acid—Discomfort—Etoposide—lung cancer	0.000197	0.00208	CcSEcCtD
Ethacrynic acid—Pain—Irinotecan—lung cancer	0.000196	0.00207	CcSEcCtD
Ethacrynic acid—Anxiety—Paclitaxel—lung cancer	0.000195	0.00205	CcSEcCtD
Ethacrynic acid—Decreased appetite—Gemcitabine—lung cancer	0.000194	0.00205	CcSEcCtD
Ethacrynic acid—Nausea—Topotecan—lung cancer	0.000193	0.00204	CcSEcCtD
Ethacrynic acid—Discomfort—Paclitaxel—lung cancer	0.000193	0.00204	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Methotrexate—lung cancer	0.000193	0.00203	CcSEcCtD
Ethacrynic acid—Fatigue—Gemcitabine—lung cancer	0.000193	0.00203	CcSEcCtD
Ethacrynic acid—Confusional state—Etoposide—lung cancer	0.000192	0.00203	CcSEcCtD
Ethacrynic acid—Pain—Gemcitabine—lung cancer	0.000191	0.00202	CcSEcCtD
Ethacrynic acid—Nausea—Erlotinib—lung cancer	0.000191	0.00202	CcSEcCtD
Ethacrynic acid—Diarrhoea—Vinorelbine—lung cancer	0.00019	0.00201	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Irinotecan—lung cancer	0.000189	0.002	CcSEcCtD
Ethacrynic acid—Confusional state—Paclitaxel—lung cancer	0.000189	0.00199	CcSEcCtD
Ethacrynic acid—Neutropenia—Methotrexate—lung cancer	0.000188	0.00198	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Etoposide—lung cancer	0.000187	0.00197	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Doxorubicin—lung cancer	0.000186	0.00196	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Gemcitabine—lung cancer	0.000184	0.00194	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Paclitaxel—lung cancer	0.000183	0.00193	CcSEcCtD
Ethacrynic acid—Anorexia—Etoposide—lung cancer	0.000182	0.00192	CcSEcCtD
Ethacrynic acid—Body temperature increased—Irinotecan—lung cancer	0.000181	0.00192	CcSEcCtD
Ethacrynic acid—Decreased appetite—Cisplatin—lung cancer	0.000181	0.00191	CcSEcCtD
Ethacrynic acid—Anorexia—Paclitaxel—lung cancer	0.000178	0.00188	CcSEcCtD
Ethacrynic acid—Pain—Cisplatin—lung cancer	0.000178	0.00188	CcSEcCtD
Ethacrynic acid—Vomiting—Vinorelbine—lung cancer	0.000177	0.00187	CcSEcCtD
Ethacrynic acid—Body temperature increased—Gemcitabine—lung cancer	0.000177	0.00187	CcSEcCtD
Ethacrynic acid—Rash—Vinorelbine—lung cancer	0.000175	0.00185	CcSEcCtD
Ethacrynic acid—Dermatitis—Vinorelbine—lung cancer	0.000175	0.00185	CcSEcCtD
Ethacrynic acid—Headache—Vinorelbine—lung cancer	0.000174	0.00184	CcSEcCtD
Ethacrynic acid—Dysphagia—Doxorubicin—lung cancer	0.000174	0.00184	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Cisplatin—lung cancer	0.000172	0.00181	CcSEcCtD
Ethacrynic acid—Haematuria—Methotrexate—lung cancer	0.000171	0.0018	CcSEcCtD
Ethacrynic acid—Convulsion—Docetaxel—lung cancer	0.000168	0.00178	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Methotrexate—lung cancer	0.000167	0.00177	CcSEcCtD
Ethacrynic acid—Decreased appetite—Etoposide—lung cancer	0.000166	0.00175	CcSEcCtD
Ethacrynic acid—Nausea—Vinorelbine—lung cancer	0.000165	0.00174	CcSEcCtD
Ethacrynic acid—Body temperature increased—Cisplatin—lung cancer	0.000165	0.00174	CcSEcCtD
Ethacrynic acid—Asthenia—Irinotecan—lung cancer	0.000165	0.00174	CcSEcCtD
Ethacrynic acid—Fatigue—Etoposide—lung cancer	0.000165	0.00174	CcSEcCtD
Ethacrynic acid—Pain—Etoposide—lung cancer	0.000163	0.00172	CcSEcCtD
Ethacrynic acid—Neutropenia—Doxorubicin—lung cancer	0.000163	0.00172	CcSEcCtD
Ethacrynic acid—Decreased appetite—Paclitaxel—lung cancer	0.000163	0.00172	CcSEcCtD
Ethacrynic acid—Fatigue—Paclitaxel—lung cancer	0.000161	0.0017	CcSEcCtD
Ethacrynic acid—Asthenia—Gemcitabine—lung cancer	0.00016	0.00169	CcSEcCtD
Ethacrynic acid—Pain—Paclitaxel—lung cancer	0.00016	0.00169	CcSEcCtD
Ethacrynic acid—Confusional state—Docetaxel—lung cancer	0.00016	0.00169	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Etoposide—lung cancer	0.000157	0.00166	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—lung cancer	0.000157	0.00166	CcSEcCtD
Ethacrynic acid—Diarrhoea—Irinotecan—lung cancer	0.000157	0.00166	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Docetaxel—lung cancer	0.000155	0.00164	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Paclitaxel—lung cancer	0.000154	0.00163	CcSEcCtD
Ethacrynic acid—Diarrhoea—Gemcitabine—lung cancer	0.000153	0.00161	CcSEcCtD
Ethacrynic acid—Jaundice—Doxorubicin—lung cancer	0.000151	0.0016	CcSEcCtD
Ethacrynic acid—Anorexia—Docetaxel—lung cancer	0.000151	0.0016	CcSEcCtD
Ethacrynic acid—Body temperature increased—Etoposide—lung cancer	0.000151	0.00159	CcSEcCtD
Ethacrynic acid—Tinnitus—Methotrexate—lung cancer	0.00015	0.00158	CcSEcCtD
Ethacrynic acid—Asthenia—Cisplatin—lung cancer	0.000149	0.00158	CcSEcCtD
Ethacrynic acid—Haematuria—Doxorubicin—lung cancer	0.000148	0.00156	CcSEcCtD
Ethacrynic acid—Body temperature increased—Paclitaxel—lung cancer	0.000148	0.00156	CcSEcCtD
Ethacrynic acid—Vomiting—Irinotecan—lung cancer	0.000146	0.00154	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Doxorubicin—lung cancer	0.000145	0.00153	CcSEcCtD
Ethacrynic acid—Rash—Irinotecan—lung cancer	0.000145	0.00153	CcSEcCtD
Ethacrynic acid—Dermatitis—Irinotecan—lung cancer	0.000145	0.00153	CcSEcCtD
Ethacrynic acid—Chills—Methotrexate—lung cancer	0.000144	0.00152	CcSEcCtD
Ethacrynic acid—Headache—Irinotecan—lung cancer	0.000144	0.00152	CcSEcCtD
Ethacrynic acid—Diarrhoea—Cisplatin—lung cancer	0.000143	0.00151	CcSEcCtD
Ethacrynic acid—Vomiting—Gemcitabine—lung cancer	0.000142	0.0015	CcSEcCtD
Ethacrynic acid—Rash—Gemcitabine—lung cancer	0.000141	0.00149	CcSEcCtD
Ethacrynic acid—Dermatitis—Gemcitabine—lung cancer	0.000141	0.00149	CcSEcCtD
Ethacrynic acid—Headache—Gemcitabine—lung cancer	0.00014	0.00148	CcSEcCtD
Ethacrynic acid—Decreased appetite—Docetaxel—lung cancer	0.000138	0.00146	CcSEcCtD
Ethacrynic acid—Asthenia—Etoposide—lung cancer	0.000137	0.00145	CcSEcCtD
Ethacrynic acid—Fatigue—Docetaxel—lung cancer	0.000137	0.00144	CcSEcCtD
Ethacrynic acid—Nausea—Irinotecan—lung cancer	0.000136	0.00144	CcSEcCtD
Ethacrynic acid—Pain—Docetaxel—lung cancer	0.000136	0.00143	CcSEcCtD
Ethacrynic acid—Asthenia—Paclitaxel—lung cancer	0.000134	0.00142	CcSEcCtD
Ethacrynic acid—Nausea—Gemcitabine—lung cancer	0.000133	0.0014	CcSEcCtD
Ethacrynic acid—Vomiting—Cisplatin—lung cancer	0.000132	0.0014	CcSEcCtD
Ethacrynic acid—Vision blurred—Methotrexate—lung cancer	0.000132	0.00139	CcSEcCtD
Ethacrynic acid—Rash—Cisplatin—lung cancer	0.000131	0.00139	CcSEcCtD
Ethacrynic acid—Dermatitis—Cisplatin—lung cancer	0.000131	0.00139	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Docetaxel—lung cancer	0.000131	0.00138	CcSEcCtD
Ethacrynic acid—Diarrhoea—Etoposide—lung cancer	0.000131	0.00138	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Methotrexate—lung cancer	0.00013	0.00137	CcSEcCtD
Ethacrynic acid—Tinnitus—Doxorubicin—lung cancer	0.00013	0.00137	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000129	0.00156	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000129	0.00156	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Paclitaxel—lung cancer	0.000128	0.00135	CcSEcCtD
Ethacrynic acid—Malaise—Methotrexate—lung cancer	0.000126	0.00133	CcSEcCtD
Ethacrynic acid—Vertigo—Methotrexate—lung cancer	0.000126	0.00133	CcSEcCtD
Ethacrynic acid—Body temperature increased—Docetaxel—lung cancer	0.000125	0.00132	CcSEcCtD
Ethacrynic acid—Chills—Doxorubicin—lung cancer	0.000125	0.00132	CcSEcCtD
Ethacrynic acid—Nausea—Cisplatin—lung cancer	0.000124	0.00131	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PLBD1—lung cancer	0.000123	0.00148	CbGpPWpGaD
Ethacrynic acid—Convulsion—Methotrexate—lung cancer	0.000121	0.00128	CcSEcCtD
Ethacrynic acid—Vomiting—Etoposide—lung cancer	0.000121	0.00128	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—TF—lung cancer	0.00012	0.00145	CbGpPWpGaD
Ethacrynic acid—Rash—Etoposide—lung cancer	0.00012	0.00127	CcSEcCtD
Ethacrynic acid—Dermatitis—Etoposide—lung cancer	0.00012	0.00127	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—TF—lung cancer	0.00012	0.00144	CbGpPWpGaD
Ethacrynic acid—Headache—Etoposide—lung cancer	0.00012	0.00126	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion channel transport—RAF1—lung cancer	0.000119	0.00143	CbGpPWpGaD
Ethacrynic acid—Vomiting—Paclitaxel—lung cancer	0.000119	0.00126	CcSEcCtD
Ethacrynic acid—Rash—Paclitaxel—lung cancer	0.000118	0.00125	CcSEcCtD
Ethacrynic acid—Dermatitis—Paclitaxel—lung cancer	0.000118	0.00124	CcSEcCtD
Ethacrynic acid—Discomfort—Methotrexate—lung cancer	0.000118	0.00124	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000118	0.00141	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000118	0.00141	CbGpPWpGaD
Ethacrynic acid—Headache—Paclitaxel—lung cancer	0.000117	0.00124	CcSEcCtD
Ethacrynic acid—Confusional state—Methotrexate—lung cancer	0.000115	0.00122	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TF—lung cancer	0.000114	0.00137	CbGpPWpGaD
Ethacrynic acid—Vision blurred—Doxorubicin—lung cancer	0.000114	0.00121	CcSEcCtD
Ethacrynic acid—Asthenia—Docetaxel—lung cancer	0.000114	0.0012	CcSEcCtD
Ethacrynic acid—Nausea—Etoposide—lung cancer	0.000113	0.0012	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—HSD17B10—lung cancer	0.000113	0.00135	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SOD2—lung cancer	0.000113	0.00135	CbGpPWpGaD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—lung cancer	0.000113	0.00119	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Methotrexate—lung cancer	0.000112	0.00118	CcSEcCtD
Ethacrynic acid—Nausea—Paclitaxel—lung cancer	0.000111	0.00117	CcSEcCtD
Ethacrynic acid—Malaise—Doxorubicin—lung cancer	0.000109	0.00115	CcSEcCtD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—TF—lung cancer	0.000109	0.00131	CbGpPWpGaD
Ethacrynic acid—Vertigo—Doxorubicin—lung cancer	0.000109	0.00115	CcSEcCtD
Ethacrynic acid—Anorexia—Methotrexate—lung cancer	0.000109	0.00115	CcSEcCtD
Ethacrynic acid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—lung cancer	0.000109	0.0013	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Docetaxel—lung cancer	0.000109	0.00115	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—APP—lung cancer	0.000107	0.00129	CbGpPWpGaD
Ethacrynic acid—Convulsion—Doxorubicin—lung cancer	0.000105	0.00111	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CKB—lung cancer	0.000105	0.00126	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000103	0.00124	CbGpPWpGaD
Ethacrynic acid—Anxiety—Doxorubicin—lung cancer	0.000103	0.00109	CcSEcCtD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.000103	0.00123	CbGpPWpGaD
Ethacrynic acid—Discomfort—Doxorubicin—lung cancer	0.000102	0.00108	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—APP—lung cancer	0.000102	0.00122	CbGpPWpGaD
Ethacrynic acid—Vomiting—Docetaxel—lung cancer	0.000101	0.00106	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000101	0.00121	CbGpPWpGaD
Ethacrynic acid—Rash—Docetaxel—lung cancer	0.0001	0.00106	CcSEcCtD
Ethacrynic acid—Dermatitis—Docetaxel—lung cancer	9.99e-05	0.00105	CcSEcCtD
Ethacrynic acid—Confusional state—Doxorubicin—lung cancer	9.98e-05	0.00105	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—ALB—lung cancer	9.95e-05	0.00119	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Methotrexate—lung cancer	9.94e-05	0.00105	CcSEcCtD
Ethacrynic acid—Headache—Docetaxel—lung cancer	9.94e-05	0.00105	CcSEcCtD
Ethacrynic acid—Fatigue—Methotrexate—lung cancer	9.86e-05	0.00104	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTM2—lung cancer	9.86e-05	0.00118	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CNDP2—lung cancer	9.86e-05	0.00118	CbGpPWpGaD
Ethacrynic acid—Pain—Methotrexate—lung cancer	9.78e-05	0.00103	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—lung cancer	9.69e-05	0.00102	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—CAT—lung cancer	9.66e-05	0.00116	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTMR3—lung cancer	9.59e-05	0.00115	CbGpPWpGaD
Ethacrynic acid—Anorexia—Doxorubicin—lung cancer	9.44e-05	0.000996	CcSEcCtD
Ethacrynic acid—Nausea—Docetaxel—lung cancer	9.42e-05	0.000995	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Methotrexate—lung cancer	9.42e-05	0.000995	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PGAM1—lung cancer	9.34e-05	0.00112	CbGpPWpGaD
Ethacrynic acid—ALB—Lipid and lipoprotein metabolism—APOA1—lung cancer	9.27e-05	0.00111	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—SOD2—lung cancer	9.16e-05	0.0011	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—APOA1—lung cancer	9.12e-05	0.0011	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Methotrexate—lung cancer	9.04e-05	0.000954	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CYP2A7—lung cancer	8.91e-05	0.00107	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SDC4—lung cancer	8.72e-05	0.00105	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Doxorubicin—lung cancer	8.6e-05	0.000909	CcSEcCtD
Ethacrynic acid—Fatigue—Doxorubicin—lung cancer	8.53e-05	0.000901	CcSEcCtD
Ethacrynic acid—Pain—Doxorubicin—lung cancer	8.46e-05	0.000894	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—AVP—lung cancer	8.34e-05	0.001	CbGpPWpGaD
Ethacrynic acid—Asthenia—Methotrexate—lung cancer	8.2e-05	0.000866	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Doxorubicin—lung cancer	8.16e-05	0.000861	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ABCB1—lung cancer	8.08e-05	0.00097	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—RRM1—lung cancer	7.94e-05	0.000954	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTA3—lung cancer	7.94e-05	0.000954	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	7.94e-05	0.000954	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Doxorubicin—lung cancer	7.83e-05	0.000826	CcSEcCtD
Ethacrynic acid—Diarrhoea—Methotrexate—lung cancer	7.82e-05	0.000826	CcSEcCtD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—CD9—lung cancer	7.77e-05	0.000933	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—CAT—lung cancer	7.68e-05	0.000922	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—AVP—lung cancer	7.58e-05	0.00091	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—B4GALT5—lung cancer	7.47e-05	0.000897	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—APOA1—lung cancer	7.42e-05	0.000891	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ABCB1—lung cancer	7.34e-05	0.000881	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SOD2—lung cancer	7.28e-05	0.000874	CbGpPWpGaD
Ethacrynic acid—Vomiting—Methotrexate—lung cancer	7.27e-05	0.000767	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GSTA4—lung cancer	7.27e-05	0.000873	CbGpPWpGaD
Ethacrynic acid—Rash—Methotrexate—lung cancer	7.21e-05	0.000761	CcSEcCtD
Ethacrynic acid—Dermatitis—Methotrexate—lung cancer	7.2e-05	0.00076	CcSEcCtD
Ethacrynic acid—Headache—Methotrexate—lung cancer	7.16e-05	0.000756	CcSEcCtD
Ethacrynic acid—Asthenia—Doxorubicin—lung cancer	7.1e-05	0.00075	CcSEcCtD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC34A2—lung cancer	6.91e-05	0.000829	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTA1—lung cancer	6.83e-05	0.00082	CbGpPWpGaD
Ethacrynic acid—Nausea—Methotrexate—lung cancer	6.79e-05	0.000717	CcSEcCtD
Ethacrynic acid—Diarrhoea—Doxorubicin—lung cancer	6.77e-05	0.000715	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ABCC3—lung cancer	6.75e-05	0.000811	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKR1C1—lung cancer	6.54e-05	0.000786	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—APOA1—lung cancer	6.38e-05	0.000766	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—GNG11—lung cancer	6.37e-05	0.000765	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—APOA1—lung cancer	6.36e-05	0.000764	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—UGT1A1—lung cancer	6.35e-05	0.000763	CbGpPWpGaD
Ethacrynic acid—Vomiting—Doxorubicin—lung cancer	6.29e-05	0.000665	CcSEcCtD
Ethacrynic acid—Rash—Doxorubicin—lung cancer	6.24e-05	0.000659	CcSEcCtD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	6.24e-05	0.000749	CbGpPWpGaD
Ethacrynic acid—Dermatitis—Doxorubicin—lung cancer	6.24e-05	0.000658	CcSEcCtD
Ethacrynic acid—Headache—Doxorubicin—lung cancer	6.2e-05	0.000655	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—GNG11—lung cancer	6.12e-05	0.000736	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PPIA—lung cancer	6.11e-05	0.000734	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFC—lung cancer	6.07e-05	0.000729	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—ALDOA—lung cancer	6.07e-05	0.000729	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—lung cancer	6.06e-05	0.000728	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	6.03e-05	0.000724	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	6.02e-05	0.000723	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—APOA1—lung cancer	5.9e-05	0.000708	CbGpPWpGaD
Ethacrynic acid—Nausea—Doxorubicin—lung cancer	5.88e-05	0.000621	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ALDOA—lung cancer	5.83e-05	0.0007	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KIF5B—lung cancer	5.82e-05	0.000699	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—APOA1—lung cancer	5.79e-05	0.000696	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—EGF—lung cancer	5.74e-05	0.00069	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NCOA3—lung cancer	5.66e-05	0.00068	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCG2—lung cancer	5.51e-05	0.000661	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ADCY1—lung cancer	5.51e-05	0.000661	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—EGF—lung cancer	5.47e-05	0.000657	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	5.47e-05	0.000657	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.4e-05	0.000649	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ENO2—lung cancer	5.4e-05	0.000649	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—HPGDS—lung cancer	5.4e-05	0.000649	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPP2R1B—lung cancer	5.37e-05	0.000644	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TF—lung cancer	5.33e-05	0.00064	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTT1—lung cancer	5.24e-05	0.000629	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC22A18—lung cancer	5.23e-05	0.000629	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GCLC—lung cancer	5.18e-05	0.000622	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP2A6—lung cancer	5.18e-05	0.000622	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ALB—lung cancer	5.05e-05	0.000607	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	4.92e-05	0.000591	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	4.92e-05	0.000591	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ENO1—lung cancer	4.91e-05	0.000589	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.9e-05	0.000589	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KDM1A—lung cancer	4.78e-05	0.000574	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL2—lung cancer	4.77e-05	0.000573	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—APP—lung cancer	4.75e-05	0.00057	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	4.68e-05	0.000562	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ALB—lung cancer	4.59e-05	0.000551	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—RAF1—lung cancer	4.57e-05	0.000549	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	4.57e-05	0.000549	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP2E1—lung cancer	4.4e-05	0.000529	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NQO1—lung cancer	4.35e-05	0.000523	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—RAF1—lung cancer	4.15e-05	0.000499	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—lung cancer	4.09e-05	0.000491	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CD9—lung cancer	4.01e-05	0.000481	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—STK11—lung cancer	3.92e-05	0.000471	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	3.78e-05	0.000454	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—lung cancer	3.63e-05	0.000436	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	3.58e-05	0.00043	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—COL4A3BP—lung cancer	3.54e-05	0.000425	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AZIN2—lung cancer	3.54e-05	0.000425	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CAT—lung cancer	3.53e-05	0.000424	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—lung cancer	3.47e-05	0.000417	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—FGR—lung cancer	3.47e-05	0.000417	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—lung cancer	3.44e-05	0.000414	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCB1—lung cancer	3.44e-05	0.000413	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TYMS—lung cancer	3.38e-05	0.000405	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—lung cancer	3.34e-05	0.000401	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—lung cancer	3.31e-05	0.000398	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.3e-05	0.000396	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GNG11—lung cancer	3.28e-05	0.000394	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—AVP—lung cancer	3.24e-05	0.000389	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.19e-05	0.000384	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	3.17e-05	0.000381	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A1—lung cancer	3.16e-05	0.00038	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PPIA—lung cancer	3.15e-05	0.000378	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ERCC2—lung cancer	3.14e-05	0.000377	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCC3—lung cancer	3.14e-05	0.000377	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ALDOA—lung cancer	3.13e-05	0.000376	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFC—lung cancer	3.13e-05	0.000376	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	3.07e-05	0.000369	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—lung cancer	3.06e-05	0.000368	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ATP5H—lung cancer	3.01e-05	0.000361	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PPP2R1B—lung cancer	2.88e-05	0.000346	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GNG11—lung cancer	2.84e-05	0.000341	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—APOA1—lung cancer	2.82e-05	0.000339	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—lung cancer	2.8e-05	0.000337	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.76e-05	0.000332	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TF—lung cancer	2.75e-05	0.00033	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—APOA1—lung cancer	2.71e-05	0.000326	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IRF1—lung cancer	2.69e-05	0.000323	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PLBD1—lung cancer	2.68e-05	0.000322	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.64e-05	0.000317	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	2.58e-05	0.00031	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ADCY1—lung cancer	2.56e-05	0.000307	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCG2—lung cancer	2.56e-05	0.000307	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—EGF—lung cancer	2.55e-05	0.000306	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CG—lung cancer	2.48e-05	0.000298	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD17B10—lung cancer	2.45e-05	0.000294	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—APP—lung cancer	2.45e-05	0.000294	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	2.42e-05	0.000291	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—TF—lung cancer	2.38e-05	0.000285	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—POMC—lung cancer	2.36e-05	0.000283	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CREBBP—lung cancer	2.3e-05	0.000276	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CKB—lung cancer	2.28e-05	0.000274	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	2.27e-05	0.000272	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—lung cancer	2.23e-05	0.000267	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CD—lung cancer	2.18e-05	0.000262	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALB—lung cancer	2.15e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CNDP2—lung cancer	2.14e-05	0.000257	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM2—lung cancer	2.14e-05	0.000257	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTMR3—lung cancer	2.08e-05	0.00025	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.05e-05	0.000246	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PGAM1—lung cancer	2.03e-05	0.000244	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	2.02e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	1.97e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGB1—lung cancer	1.96e-05	0.000235	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2A7—lung cancer	1.94e-05	0.000233	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	1.92e-05	0.000231	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CB—lung cancer	1.9e-05	0.000228	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SDC4—lung cancer	1.9e-05	0.000228	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—lung cancer	1.88e-05	0.000226	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	1.81e-05	0.000218	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	1.74e-05	0.000209	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA3—lung cancer	1.73e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—RRM1—lung cancer	1.73e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—AVP—lung cancer	1.65e-05	0.000198	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTEN—lung cancer	1.64e-05	0.000197	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—B4GALT5—lung cancer	1.62e-05	0.000195	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	1.6e-05	0.000192	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	1.58e-05	0.00019	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA4—lung cancer	1.58e-05	0.00019	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—EP300—lung cancer	1.56e-05	0.000188	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.54e-05	0.000185	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	1.54e-05	0.000185	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA2—lung cancer	1.54e-05	0.000185	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MMP1—lung cancer	1.52e-05	0.000183	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA1—lung cancer	1.49e-05	0.000178	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCC3—lung cancer	1.47e-05	0.000176	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.46e-05	0.000175	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—APOA1—lung cancer	1.46e-05	0.000175	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKR1C1—lung cancer	1.42e-05	0.000171	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UGT1A1—lung cancer	1.38e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GNG11—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CG—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.32e-05	0.000159	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EGF—lung cancer	1.31e-05	0.000158	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDOA—lung cancer	1.27e-05	0.000152	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.26e-05	0.000151	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CREBBP—lung cancer	1.23e-05	0.000148	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA3—lung cancer	1.23e-05	0.000148	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.21e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.2e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADCY1—lung cancer	1.2e-05	0.000144	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCG2—lung cancer	1.2e-05	0.000144	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENO2—lung cancer	1.17e-05	0.000141	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPGDS—lung cancer	1.17e-05	0.000141	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CD—lung cancer	1.17e-05	0.00014	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPP2R1B—lung cancer	1.17e-05	0.00014	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—lung cancer	1.16e-05	0.000139	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.15e-05	0.000138	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—lung cancer	1.14e-05	0.000137	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GCLC—lung cancer	1.13e-05	0.000135	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2A6—lung cancer	1.13e-05	0.000135	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.12e-05	0.000135	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ENO1—lung cancer	1.07e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.07e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.06e-05	0.000128	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RAF1—lung cancer	1.04e-05	0.000125	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CB—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	9.83e-06	0.000118	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2E1—lung cancer	9.57e-06	0.000115	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NQO1—lung cancer	9.46e-06	0.000114	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKT1—lung cancer	9.45e-06	0.000114	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—lung cancer	9.35e-06	0.000112	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.27e-06	0.000111	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.18e-06	0.00011	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	9.02e-06	0.000108	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—STK11—lung cancer	8.53e-06	0.000102	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EP300—lung cancer	8.39e-06	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SRC—lung cancer	8.16e-06	9.8e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.01e-06	9.62e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—lung cancer	7.94e-06	9.54e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—lung cancer	7.89e-06	9.48e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NRAS—lung cancer	7.85e-06	9.42e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CAT—lung cancer	7.68e-06	9.22e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.64e-06	9.17e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MAPK3—lung cancer	7.52e-06	9.03e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCB1—lung cancer	7.47e-06	8.97e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TYMS—lung cancer	7.34e-06	8.81e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—lung cancer	7.25e-06	8.71e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A1—lung cancer	6.88e-06	8.26e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ERCC2—lung cancer	6.82e-06	8.19e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—lung cancer	6.75e-06	8.11e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—lung cancer	6.2e-06	7.45e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—lung cancer	6e-06	7.21e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APOA1—lung cancer	5.9e-06	7.09e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—HRAS—lung cancer	5.74e-06	6.89e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.65e-06	6.78e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CG—lung cancer	5.39e-06	6.47e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—POMC—lung cancer	5.13e-06	6.16e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT1—lung cancer	5.07e-06	6.09e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CREBBP—lung cancer	4.99e-06	6e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CD—lung cancer	4.73e-06	5.69e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CB—lung cancer	4.13e-06	4.96e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—lung cancer	4.09e-06	4.91e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTEN—lung cancer	3.57e-06	4.28e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—EP300—lung cancer	3.4e-06	4.08e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—lung cancer	2.52e-06	3.02e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKT1—lung cancer	2.06e-06	2.47e-05	CbGpPWpGaD
